Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease

By Pothula A.   Serebruany V.L.   Gurbel P.   McKenzie M.E.   Atar D.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors as Immunomodulators: Potential Use in Transplant Rejection

By Raggatt L.J.   Partridge N.C.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2185-2191

Adis International

Access to resources Recommend Favorite

Can Amiodarone Prevent Sudden Cardiac Death in Patients with Hemodynamically Tolerated Sustained Ventricular Tachycardia and Coronary Artery Disease?

By Arya Arash   Haghjoo Majid   Sadr-Ameli Mohammad  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 3, 2005-05 ,pp. : 219-226

Springer Publishing Company

Access to resources Recommend Favorite

Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery

By Broglio F.   Guarracino F.   Benso A.   Gottero C.   Prodam F.   Granata R.   Avogadri E.   Muccioli G.   Deghenghi R.   Ghigo E.  

European Journal of Pharmacology, Vol. 448, Iss. 2, 2002-07 ,pp. : 193-200

Elsevier

Access to resources Recommend Favorite

Add-On Benefit to Coronary Artery Bypass Grafting of Treatment with Ramipril for Major Cardiac Events and Left Ventricular Remodeling in Intermediate-Risk Patients

By  

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 73-81

Karger

Access to resources Recommend Favorite